Boolean network-based model of the Bcl-2 family mediated MOMP regulation

Theoretical Biology and Medical Modelling

Volumn 10, Issue 1, 2013, Pages

  Tokar, Tomas ^a   Turcan, Zdenko ^a   Ulicny, Jozef ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Apoptosis; Bcl 2 family; Boolean network; Mitochondrial outer membrane permeabilisation

Indexed keywords

PROTEIN BCL 2;

ARTICLE; INFORMATION RETRIEVAL; METABOLISM; MITOCHONDRIAL MEMBRANE;

INFORMATION STORAGE AND RETRIEVAL; MITOCHONDRIAL MEMBRANES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84878894642     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-10-40     Document Type: Article

References (60)

1. Apoptosis: why and how does it occur in biology? Ulukava E, Acilan C, Yilmaz Y, Cell Biochem Funct 2011 29 468 80
2. "Where, o death, is thy sting?" A brief review of apoptosis biology. Wyllie AH, Mol Neurobiol 2010 42 4 9
3. Apoptosis: a review of programmed cell death. Elmore S, Toxicol Pathol 2007 35 495 516 (Pubitemid 46911891)
4. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Mattson MP, Antioxid Redox Signal 2006 8 1997 2006 (Pubitemid 46489627)
5. Apoptosis and autoimmune diseases. Nagata S, Ann N Y Acad Sci 2010 1209 10 16
6. Apoptosis in cancer: Key molecular signaling pathways and therapy targets. Burz C, Berindan-Neagoe I, Balacescu O, Irimie A, Acta Oncol 2009 48 811 821
7. Tumor resistance to apoptosis. Fulda S, Int J Cancer 2009 124 511 515
8. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. Strasser A, Cory S, Adams JM, EMBO J 2011 30 3667 3683
9. Apoptosis signaling. Strasser A, O'Connor L, Dixit VM, Annu Rev Biochem 2000 69 217 245
10. Cell death: critical control points. Danial NN, Korsmeyer SJ, Cell 2004 116 205 219 (Pubitemid 38167313)
11. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Chipuk JE, Green DR, Trends Cell Biol 2008 18 157 164
12. Mitochondria and cell death: outer membrane permeabilization and beyond. Tait SWG, Green DR, Nat Rev Mol Cell Biol 2010 11 621 632
13. Mitochondrial outer membrane permeabilization during apoptosis: the role of mitochondrial fission. Landes T, Martinou JC, Biochim Biophys Acta 2011 1813 540 545
14. Molecular cell death platforms and assemblies. Mace PD, Riedl SJ, Curr Opin Cell Biol 2010 22 828 836
15. Molecules that modulate Apaf-1 activity. Perez-Paya E, Orzaez M, Mondragon L, Wolan D, Wells JA, Messequer A, Vincent MJ, Med Res Rev 2011 31 649 675
16. Cytochrome c: the Achilles' heel in apoptosis. Kulikov AV, Shilov ES, Mufazalov IA, Gogvadze V, Nedospasov SA, Zhivotinsky B, Cell Mol Life Sci 2012 69 1787 1797
17. The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome. Wurstle ML, Laussmann MA, Rehm M, Exp Cell Res 2012 318 1213 1220
18. Role of Smac/DIABLO in cancer progression. Martinez-Ruiz G, Maldonado V, Caballos-Cancino G, Grajeda JP, Melendez-Zajgla J, J Exp Clin Cancer Res 2008 27 48
19. Capases and cancer. Olsson M, Zhivotinsky B, Cell Death Differ 2011 18 1441 1449
20. The point of no return: mitochondria, caspases, and the commitment to cell death. Green DR, Amarate-Mendes GB, Results Probl Cell Differ 1999 24 45 61
21. The extrinsic cell death pathway and the elan mortel. Wallach D, Kang TB, Kovalenko A, Cell Death Differ 2008 15 1533 1541
22. The mitochondrial pathways of apoptosis. Estaquier J, Vallette F, Vayssiere JL, Mignotte B, Adv Exp Med Biol 2012 942 157 183
23. Robustness analysis identifies the plausible model of the Bcl-2 apoptotic switch. Chen C, Cui J, Zhang W, Shen P, FEBS Lett 2007 581 5143 5150 (Pubitemid 47576101)
24. Two independent positive feedbacks and bistability in the Bcl-2 apoptotic switch. Cui J, Chen C, Lu H, Sun T, Shen P, PLoS ONE 2008 3 1469
25. Evaluating bistability of Bax activation switch. Sun T, Lin X, Wei Y, Xu Y, Shen P, FEBS Lett 2010 584 954 960
26. Computational study of Bcl-2 apoptotic switch. Tokar T, Ulicny J, Physica A 2012 391 6212 6225
27. Bistability in Apoptosis: Roles of Bax, Bcl-2, and Mitochondrial Permeability Transition Pores. Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I, Biophys J 2006 90 1546 1559
28. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. Abeck JG, Burke JM, Aldridge BB, Zhang M, Lauffenburger DA, Sorger PK, Mole Cell 2008 30 11 25 (Pubitemid 351470145)
29. Construction and analysis of a modular model of caspase activation in apoptosis. Harrington H, Lo KL, Ghosh S, Tung K, Theor Biol Med Model 2008 90 1546 1559
30. ON/OFF and beyond-a boolean model of apoptosis. Schlatter R, Schmich K, Avalos Vizcarra I, Scheurich P, Sauter T, Borner C, Ederer M, Merfort I, Sawodny O, PLoS Comput Biol 2009 5 1000595
31. Differential targeting of prosurvival Bcl-2 proteins by their BH3-Only ligands allows complementary apoptotic function. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DCS, Molecular Cell 2005 17 393 403 (Pubitemid 40193310)
32. Context-dependent Bcl-2/Bak interactions regulate lymphoid cell apoptosis. Dai H, Meng XW, Lee SH, Schneider PA, Kaufmann SH, J Biol Chem 2009 284 18311 18322
33. Single-cell quantification of Bax activation and mathematical modelling suggest pore formation on minimal mitochondrial Bax accumulation. Düssmann H, Rehm M, Concannon CG, Anguissola S, Würstle M, Kacmar S, Völler P, Huber HJ, Prehn JHM, Cell Death Diff 2009 17 278 290
34. Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy. Lindner AU, Concannon CG, Boukes GJ, Cannon MD, Llambi F, Ryan D, Boland K, Kehoe J, McNamara DA, Murray F, Cancer Res 2013 73 519 528
35. Boolean network-based analysis of the apoptosis network: Irreversible apoptosis and stable surviving. Mai Z, Liu H, J Theor Biol 2009 259 760 769
36. Metabolic stability and epigenesis in randomly constructed genetic nets. Kauffman SA, J Theor Biol 1969 22 437 467
37. Boolean modeling of biochemical networks. Helikar T, Kochi N, Konvalina J, Rogers JA, Open Bioinform J 2011 5 16 25
38. Selective control of the apoptosis signaling network in heterogenous cell populations. Calzolari D, Paternostro D, Harrington PLJ, Piermarocchi C, Duxbury PM, PLoS One 2007 2 547
39. The role of BH3-Only proteins in tumor cell development, signaling, and treatment. Elkholi R, Floros KV, Chipuk JE, Gen Cancer 2011 2 523 537
40. The Bcl-2 Family Reunion. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, gREEN DR, Mol Cell 2010 37 299 310
41. A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy. Placzek WJ, Wei J, Kitada S, Zhai D, Reed JC, Pellecchia M, Cell Death Dis 2010 6 40
42. Molecular biology of Bax and Bak activation and action. Westhpal D, Dewson G, Czabotar PE, Kluck RM, Biochimica Biophysica Acta 2011 4 521 531
43. MAC and Bcl-2 family proteins conspire in a deadly plot. Dejean LM, Ryu SY, Martinez-Caballero S, Teijido O, Peixoto PM, Kinnally KW, Biochimica Biophysica Acta 2010 1797 1231 1238
44. The structure of Boo/Diva reveals a divergent Bcl-2 protein. Rautureau GJP, Day CL, Hinds MG, Proteins 2010 78 2181 2186
45. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Kantari C, Walczak H, Biochimica Biophysica Acta 2011 4 558 563
46. The hallmarks of cancer. Hanahan D, Weinberg RA, Cell 2000 100 57 70 (Pubitemid 30046295)
47. Dynamics of outer mitochondrial membrane permeabilization during apoptosis. Rehm M, Huber HJ, Hellwig CT, Anguissola S, Dussmann H, Prehn JHM, Cell Death Diff 2009 16 613 623
48. Bim: a novel member of the Bcl-2 family that promotes apoptosis. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S, Huang DCS, EMBO J 1998 17 384 395 (Pubitemid 28045479)
49. Role of Bim in apoptosis induced in H460 lung tumor cells by the spindle poison Combretastatin-A4. Mendez G, Policarpi C, Cenciarelli C, Tanzarella C, Antoccia A, Apoptosis 2011 16 940 949
50. Apoptosis in targeted therapy responses: the role of BIM. Faber AC, Ebi H, Costa C, Engelman JA, Adv Pharmacol 2012 65 519
51. Unique biology of Mcl-1: therapeutic opportunities in cancer. Shore GC, Warr MR, Curr Mol Med 2008 8 138 147 (Pubitemid 351516833)
52. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Polier G, Ding J, Konkimalla BV, Eick D, Ribeiro N, Köhler R, Giaisi M, Efferth T, Desaubry L, Krammer PH, Cell Death Dis 2011 2 182
53. Nonredundant role of Bax and Bak in bid-mediated Apoptosis. Carton PF, Juin P, Oliver L, Martin S, Meflah K, Vallette FM, Mol Cell Biol 2003 23 4701 4712 (Pubitemid 36734757)
54. Bak but not Bax is essential for Bcl-xS-induced apoptosis. Lindenboim L, Kringel S, Braun T, Borner C, Stein R, Cell Death Diff 2005 12 713 723 (Pubitemid 40945979)
55. Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells. Zhang W, Wang X, Chen T, Cell Signal 2012 24 1037 1046
56. Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells. Zhou C, Pan W, Wang XP, Chen TS, J Cell Phys 2012 227 3778 3786
57. Rapid kinetics of tBid-induced Cytochrome c and Smac/DIABLO release and Mitochondrial depolarization. Madesh M, Antonsson B, Srinivasula SM, Alnemri ES, Hajnoczky G, J Biol Chem 2002 277 5651 5659 (Pubitemid 34968620)
58. Real-time single cell analysis of Smac/DIABLO release during apoptosis. Rehm M, Dussmann H, Prehn JHM, J Cell Biol 2003 162 1031 1042
59. Real time analysis of tumor necrosis factor-related Apoptosis-inducing Ligand/Cycloheximide-induced Caspase activities during Apoptosis initiation. Hellwig CT, Kohler BF, Lehtivarjo AK, Dussmann H, Courtney MJ, Prehn JHM, Rehm M, J Biol Chem 2008 283 21676 21685
60. The nature of the data, or how to choose a correlation coefficient. Carroll J, Psychometrika 1961 26 347 372